Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 4, 2011, Pages 1567-1572

  Calderon, Boris ^a   Carrero, Javier A ^a   Miller, Mark J ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; T cell migration; Type 1 diabetes

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; B LYMPHOCYTE; BLOOD VESSEL; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL SPECIFICITY; CELL TRANSFER; DIABETOGENESIS; GENE EXPRESSION; PANCREAS ISLET; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; BLOOD VESSELS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; MURAMIDASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79952178124     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018975108     Document Type: Article

References (25)

1. Krishnamoorthy G, Wekerle H (2009) EAE: An immunologist's magic eye. Eur J Immunol 39:2031-2035.
2. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA, Jr. (1993) Surface expression of α 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177:57-68. (Pubitemid 23008085)
3. Katz-Levy Y, et al. (1999) Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 104:599-610.
4. Flügel A, et al. (2001) Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547-560. (Pubitemid 32520866)
5. Greter M, et al. (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328-334. (Pubitemid 40460562)
6. Kawakami N, et al. (2005) Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 201:1805-1814. (Pubitemid 41002899)
7. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393-407.
8. Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260.
9. Ransohoff RM, Kivisäkk P, Kidd G (2003) Three or more routes for leukocytemigration into the central nervous system. Nat Rev Immunol 3:569-581. (Pubitemid 37328676)
10. Archambault AS, Sim J, Gimenez MA, Russell JH (2005) Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur J Immunol 35:1076-1085. (Pubitemid 40542214)
11. Calderon B, Carrero JA, Miller MJ, Unanue ER (2011) Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci USA 108:1561-1566.
12. Calderon B, Suri A, Miller MJ, Unanue ER (2008) Dendritic cells in islets of Langerhans constitutively present β cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci USA 105:6121-6126. (Pubitemid 351758409)
13. Calderon B, Suri A, Pan XO, Mills JC, Unanue ER (2008) IFN-γ-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol 181:6964-6974.
14. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289-300.
15. MacMicking JD (2004) IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 25:601-609.
16. Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci USA 95:15623-15628. (Pubitemid 29018750)
17. Cardozo AK, Kruhøffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920. (Pubitemid 32374519)
18. Matos M, Park R, Mathis D, Benoist C (2004) Progression to islet destruction in a cyclophosphamide-induced transgenic model: A microarray overview. Diabetes 53:2310-2321. (Pubitemid 39145584)
19. Klamp T, Boehm U, Schenk D, Pfeffer K, Howard JC (2003) A giant GTPase, very large inducible GTPase-1, is inducible by IFNs. J Immunol 171:1255-1265. (Pubitemid 36900055)
20. Modiano N, Lu YE, Cresswell P (2005) Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-γ-inducible cofactor. Proc Natl Acad Sci USA 102:8680-8685. (Pubitemid 40862795)
21. Cain JA, Smith JA, Ondr JK, Wang B, Katz JD (2006) NKT cells and IFN-γ establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol 176:1645-1654. (Pubitemid 43134309)
22. Tang Q, et al. (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83-92. (Pubitemid 41823872)
23. Tang Q, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697.
24. Calderon B, Suri A, Unanue ER (2006) In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet β-cell killing: Studies from an acute model. Am J Pathol 169:2137-2147.
25. Cyster JG, Goodnow CC (1995) Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 182:581-586.